XML 24 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities      
Net loss for the year $ (5,525) $ (13,151) $ (13,125)
Adjustments for:      
Effect of exchange rate differences on cash and cash equivalents and restricted deposits balances (41) 139 (80)
Issuance costs 123
Change in financial liabilities at fair value through profit or loss 2 (462) (1,644)
Change in financial assets at fair value through profit or loss 199 (43)
Change in Israel Innovation Authority liability (182)
Interest income related to financial assets at fair value through profit or loss (16) (37)
Interest and other finance expenses related to long-term loan 239 172
Interest expenses related to short-term bank loans 102 39
Interest portion of lease payments 88 11 102
Depreciation and amortization 1,152 2,043 1,785
Impairment of goodwill and intangible assets 8,991 1,022 700
Gain from sale of discontinued operations (82)
Loss on disposal of property and equipment 8 2
Share-based payments 933 1,679 2,356
Total adjustments 11,515 4,644 3,141
Changes in asset and liability items:      
Trade receivables (204) (294) (851)
Other receivables 353 (3) 218
Trade payables (1,798) 948 944
Other payables 55 (489) 1,523
Deferred taxes (482) (344) (973)
Contract liabilities 813 638 17
Changes in operating asset and liability, total (1,263) 456 878
Net cash provided by (used in) operating activities 4,727 (8,051) (9,106)
Cash flows from investing activities      
Business combination, net of cash acquired (3,700)
Purchase of short-term investments (19) (5,844)
Sale of short-term investments 5,707
Interest income related to short-term investments 16 37
Investment in long-term deposits (51) (6) (15)
Repayment of long-term deposits 18
Investment in short-term restricted deposit (560)
Investment in long-term restricted deposits (21) (54)
Repayment of short-term restricted deposits 560
Repayment of long-term restricted deposits 136 2
Purchase of intangible assets (204)
Purchase of property and equipment (55) (49) (73)
Proceeds from sale of property and equipment 5 3
Net cash provided by (used in) investing activities 592 5,037 (9,796)
Cash flows from financing activities      
Proceeds from public and private offerings 4,256 9,750
Issuance costs in connection with public and private offerings (478) (527)
Proceeds from at-the-market offering 768
Issuance costs in connection with at-the-market offering (164)
Proceeds from exercise of options and warrants 352 3,709
Short-term bank loans received 4,800 2,700
Repayment of short-term bank loans (6,400) (1,100)
Interest expenses related to short-term bank loans (108) (33)
Long-term loans received 888 1,667
Long-term loans interest payments (276) (172)
Long-term loans principal payments (639) (75)
Other payments related to long-term loans (500)
Payment of contingent consideration (915)
Interest portion of lease payments (88) (11) (102)
Principal portion of lease payments (198) (373) (275)
Net cash provided by financing activities 2,213 2,603 11,640
Changes in cash and cash equivalents 7,532 (411) (7,262)
Effect of exchange rate changes on cash and cash equivalents 50 (127) 73
Cash and cash equivalents at beginning of the year 3,290 3,828 11,017
Cash and cash equivalents at end of the year 10,872 3,290 3,828
Supplemental disclosure of non-cash investing and financing activities:      
Shares issued in a business combination 5,808
Addition of right-of-use assets 903 40 198
Proceed for sale of discontinued operations $ 82